BioSig Technologies, Inc.

• 26/07/2023
• Seed
• $2,200,000

BioSig Technologies is an advanced digital signal processing technology company bringing never-before-seen insights to the treatment of cardiovascular arrhythmias.

Our first product, the PURE EP™ System, is an FDA 510(k) cleared non-invasive class II device, that provides superior, real-time signal visualization, allowing physicians to perform insight-based, highly targeted cardiac ablation procedures with increased procedural efficiency and efficacy. An innovation in one of the most critical areas of electrophysiology, the PURE EP™ System is revitalizing the value of the EGM, preserving elaborate cardiac signals in their original format— pure from beginning to end.

As physician advocates, we are committed to leveraging our expertise in technology, science, and engineering to address some of healthcare’s most pressing needs. We are always looking for more smart self-starters to join us on our mission of uncovering the full potential of digital signal processing.

Ready to discover your own potential? Visit www.biosig.com/join-our-team.

---

---